Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Meropenem And Vaborbactam

    Client Email Product

    Meropenem And Vaborbactam

    GLOBAL SALES INFORMATION

    MARKET PLACE

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    0

    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    0

    API REF. PRICE (USD / KG)

    0

    API Market Place

    3
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    2.00

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    16
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics
    Melinta Therapeutics Partners with BARDA to Advance Two FDA-Approved Antibiotics

    https://www.businesswire.com/news/home/20230710869070/en

    BUSINESSWIRE
    10 Jul 2023
    Share Share
    Menarini and SciClone Sign Agreement to Develop and Commercialize Vaborem
    Menarini and SciClone Sign Agreement to Develop and Commercialize Vaborem

    https://www.prnewswire.com/in/news-releases/menarini-and-sciclone-sign-exclusive-licensing-agreement-to-develop-and-commercialize-vaborem-in-china-to-treat-antimicrobial-resistant-infections-301628124.html

    PRNEWSWIRE
    21 Sep 2022
    Share Share
    MENARINI RICERCHE ANNOUNCES THE LATEST FINDINGS OF ITS VABOREM™
    MENARINI RICERCHE ANNOUNCES THE LATEST FINDINGS OF ITS VABOREM™

    https://www.menarini.com/Home/Menarini-News/News/News-details/ArticleId/2695/Menarini-Ricerche-Announces-the-Latest-Findings-of-its-Vaborem-and-Quofenix-Clinical-Studies

    PRESS RELEASE
    09 Jul 2020
    Share Share
    Rempex's Vabomere (meropenem trihydrate, vaborbactam) Receives Approval in Europe
    Rempex's Vabomere (meropenem trihydrate, vaborbactam) Receives Approval in Europe

    https://www.ema.europa.eu/documents/product-information/vabomere-epar-product-information_en.pdf

    EMA
    19 Dec 2018
    Share Share
    Medicines Co execs grab a $33M A round to spin out an infectious disease outfit with a pipeline
    Medicines Co execs grab a $33M A round to spin out an infectious disease outfit with a pipeline

    https://endpts.com/medicines-co-execs-grab-a-33m-a-round-to-spin-out-an-infectious-disease-outfit-with-a-pipeline/

    ENDPTS
    23 Oct 2018
    Share Share
    Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin
    Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin

    https://www.prnewswire.com/news-releases/menarini-group-anuncia-un-acuerdo-comercial-para-vabomere-orbactiv-y-minocin-en-68-pa%C3%ADses-861609999.html

    PR NEWSWIRE
    11 Oct 2018
    Share Share
    Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin
    Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin

    https://www.prnewswire.com/news-releases/menarini-group-anuncia-un-acuerdo-comercial-para-vabomere-orbactiv-y-minocin-en-68-pa%C3%ADses-861609999.html

    PR NEWSWIRE
    11 Oct 2018
    Share Share
    Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 September 2018
    Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 September 2018

    https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-17-20-september-2018

    EMA
    22 Sep 2018
    Share Share
    New medicine to treat infections in adults
    New medicine to treat infections in adults

    https://www.ema.europa.eu/documents/press-release/new-medicine-treat-infections-adults_en.pdf

    EMA
    22 Sep 2018
    Share Share
    CHMP Backs 13 New Medicines, Maintains Negative Opinion of Sarepta’s Exondys
    CHMP Backs 13 New Medicines, Maintains Negative Opinion of Sarepta’s Exondys

    https://www.raps.org/news-and-articles/news-articles/2018/9/chmp-backs-13-new-medicines-maintains-negative-op?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2021%20September

    Michael Mezher RAPS
    21 Sep 2018
    Share Share
    Melinta's Vabomere (meropenem,vaborbactam) Granted New Tech Add-On Paymt by CMS
    Melinta's Vabomere (meropenem,vaborbactam) Granted New Tech Add-On Paymt by CMS

    https://globenewswire.com/news-release/2018/08/03/1547099/0/en/Melinta-Therapeutics-Announces-Vabomere-meropenem-and-vaborbactam-Granted-New-Technology-Add-On-Payment-by-CMS.html

    GLOBENEWSWIRE
    03 Aug 2018
    Share Share
    Melinta Therapeutics Announces Closing of Underwritten Public Offering
    Melinta Therapeutics Announces Closing of Underwritten Public Offering

    http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-announces-closing-underwritten-public

    PRESS RELEASE
    29 May 2018
    Share Share
    Melinta Presents Results from VABOMERE TANGO II Trial at ECCMID 2018
    Melinta Presents Results from VABOMERE TANGO II Trial at ECCMID 2018

    http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-presents-results-vabomere-tango-ii-trial

    PRESS RELEASE
    23 Apr 2018
    Share Share
    Melinta to Highlight Commitment to Antibiotics and Product Portfolio
    Melinta to Highlight Commitment to Antibiotics and Product Portfolio

    http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-highlight-commitment-antibiotics-and

    PRESS RELEASE
    08 Mar 2018
    Share Share
    Melinta Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE™
    Melinta Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE™

    http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-publishes-complete-results-phase-3-tango-i

    PRESS RELEASE
    27 Feb 2018
    Share Share
    Melinta Completes Acquisition of The Medicines Company’s
    Melinta Completes Acquisition of The Medicines Company’s

    http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-completes-acquisition-medicines-companys

    PRESS RELEASE
    08 Jan 2018
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search